Nathan Monroe-Yavneh Litigation Attorney Patterson Belknap

Nathan Monroe-Yavneh, Associate

Publications

October 28, 2020 Firm Attorneys Author Three-Part CLO Series in Bloomberg Law

October 25, 2017 The Supreme Court’s interpretation of the biosimilars statute and the value of certainty

June 15, 2017 High Court Interprets The Biosimilars Statute — What Now?

October 27, 2015 TPP Biologics Exclusivity Period Maintains The Status Quo